D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 74 Citations 16,123 275 World Ranking 2385 National Ranking 24

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Gene
  • Biochemistry

Biochemistry, Peptide, Vasoactive intestinal peptide, Internal medicine and Endocrinology are his primary areas of study. His Biochemistry research includes themes of Stereochemistry and Neuroprotection. His Neuroprotection research is multidisciplinary, relying on both Oxidative stress, Dopamine, Antioxidant and Monoamine oxidase.

His Peptide study combines topics from a wide range of disciplines, such as Antibacterial agent, Sequence, Peptide sequence, PEGylation and Immunotherapy. His study in Vasoactive intestinal peptide is interdisciplinary in nature, drawing from both Antagonist, Receptor antagonist, Moiety and Neurotransmission. His Receptor study integrates concerns from other disciplines, such as Central nervous system and Binding site.

His most cited work include:

  • Bacterial induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome (285 citations)
  • All-D-magainin : chirality, antimicrobial activity and proteolytic resistance (278 citations)
  • Enhancement of phagocytosis - a newly found activity of substance P residing in its N-terminal tetrapeptide sequence. (276 citations)

What are the main themes of his work throughout his whole career to date?

Mati Fridkin mainly investigates Biochemistry, Peptide, Internal medicine, Endocrinology and Receptor. He interconnects Acetylcholine receptor, Molecular biology, Stereochemistry and Binding site in the investigation of issues within Peptide. The Molecular biology study combines topics in areas such as Epitope and In vitro.

His Endocrinology study frequently involves adjacent topics like Vasoactive intestinal peptide. His work deals with themes such as Antagonist and Neuroprotection, which intersect with Vasoactive intestinal peptide. As part of the same scientific family, Mati Fridkin usually focuses on Tuftsin, concentrating on Immunology and intersecting with Phosphorylcholine.

He most often published in these fields:

  • Biochemistry (37.98%)
  • Peptide (27.39%)
  • Internal medicine (22.48%)

What were the highlights of his more recent work (between 2006-2021)?

  • Biochemistry (37.98%)
  • Pharmacology (9.56%)
  • Peptide (27.39%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Biochemistry, Pharmacology, Peptide, Tuftsin and Stereochemistry. His research on Biochemistry frequently connects to adjacent areas such as Acute-phase protein. His Pharmacology research is multidisciplinary, incorporating perspectives in PEGylation, Acetylcholinesterase and Monoamine oxidase.

His studies deal with areas such as Receptor, Internal medicine, Biophysics and Endocrinology as well as Peptide. Specifically, his work in Receptor is concerned with the study of Vasoactive intestinal peptide. His studies in Tuftsin integrate themes in fields like Tumor necrosis factor alpha, Phagocytosis, Immunology, Phosphorylcholine and Biological activity.

Between 2006 and 2021, his most popular works were:

  • Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease. (110 citations)
  • Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators (107 citations)
  • Site-Activated Multifunctional Chelator with Acetylcholinesterase and Neuroprotective−Neurorestorative Moieties for Alzheimer’s Therapy (104 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Gene
  • Amino acid

Mati Fridkin spends much of his time researching Pharmacology, Biochemistry, Neuroprotection, Peptide and Oxidative stress. His biological study deals with issues like Monoamine oxidase, which deal with fields such as In vitro. Mati Fridkin studies Biochemistry, namely Lipid peroxidation.

His Neuroprotection research includes elements of Dopamine, Parkinson's disease and Monoamine oxidase inhibitor. In his articles, Mati Fridkin combines various disciplines, including Peptide and Magainin. His study focuses on the intersection of Chinese hamster ovary cell and fields such as Caspase 3 with connections in the field of Endocrinology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Enhancement of phagocytosis - a newly found activity of substance P residing in its N-terminal tetrapeptide sequence.

Z. Bar-Shavit;R. Goldman;Y. Stabinsky;P. Gottlieb.
Biochemical and Biophysical Research Communications (1980)

425 Citations

All-D-magainin : chirality, antimicrobial activity and proteolytic resistance

Roberto Bessalle;Aviva Kapitkovsky;Alfred Gorea;Itamar Shalit.
FEBS Letters (1990)

423 Citations

Bacterial induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome

Miri Blank;Ilan Krause;Mati Fridkin;Nathan Keller.
Journal of Clinical Investigation (2002)

395 Citations

Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbb protein

R.M. Kris;I. Lax;W. Gullick;M.D. Waterfield.
Cell (1985)

352 Citations

CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma

Ofer Mandelboim;Gideon Berke;Mati Fridkin;Michael Feldman.
Nature (1994)

350 Citations

Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos

Pierre Gressens;Joanna M. Hill;Illana Gozes;Mati Fridkin.
Nature (1993)

331 Citations

Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium-based drugs for diabetes

Yoram Shechter;Itzhak Goldwaser;Marina Mironchik;Mati Fridkin.
Coordination Chemistry Reviews (2003)

300 Citations

Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases.

Hailin Zheng;Lev M. Weiner;Orit Bar-Am;Silvina Epsztejn.
Bioorganic & Medicinal Chemistry (2005)

277 Citations

Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides

Miri Blank;Yehuda Shoenfeld;Shmuel Cabilly;Yehudit Heldman.
Proceedings of the National Academy of Sciences of the United States of America (1999)

266 Citations

Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.

Hailin Zheng;Shunit Gal;Lev M. Weiner;Orit Bar-Am.
Journal of Neurochemistry (2005)

265 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mati Fridkin

Illana Gozes

Illana Gozes

Tel Aviv University

Publications: 159

Pierre Gressens

Pierre Gressens

Université Paris Cité

Publications: 116

Yehuda Shoenfeld

Yehuda Shoenfeld

Sheba Medical Center

Publications: 113

Moussa B.H. Youdim

Moussa B.H. Youdim

Technion – Israel Institute of Technology

Publications: 68

Mario Delgado

Mario Delgado

Spanish National Research Council

Publications: 67

Miri Blank

Miri Blank

Sheba Medical Center

Publications: 51

Eugenio Garribba

Eugenio Garribba

University of Sassari

Publications: 43

Robert P. Millar

Robert P. Millar

University of Pretoria

Publications: 39

Giovanni Micera

Giovanni Micera

University of Sassari

Publications: 34

Terry W. Moody

Terry W. Moody

National Institutes of Health

Publications: 34

Daniele Sanna

Daniele Sanna

National Academies of Sciences, Engineering, and Medicine

Publications: 32

Edna Mozes

Edna Mozes

Weizmann Institute of Science

Publications: 32

Rosa P. Gomariz

Rosa P. Gomariz

Complutense University of Madrid

Publications: 30

Michael Sela

Michael Sela

Weizmann Institute of Science

Publications: 29

Yechiel Shai

Yechiel Shai

Weizmann Institute of Science

Publications: 29

Sara Fuchs

Sara Fuchs

Weizmann Institute of Science

Publications: 25

Trending Scientists

Marc Roper

Marc Roper

University of Strathclyde

Sudip K. Mazumder

Sudip K. Mazumder

University of Illinois at Chicago

Georgios Ellinas

Georgios Ellinas

University of Cyprus

Beng S. Ong

Beng S. Ong

Hong Kong Baptist University

Katsunari Oikawa

Katsunari Oikawa

Tohoku University

I. Plavnik

I. Plavnik

Agricultural Research Organization

Dong Jiang

Dong Jiang

Nanjing Agricultural University

Matthew P. Jacobson

Matthew P. Jacobson

University of California, San Francisco

Deborah H. Spector

Deborah H. Spector

University of California, San Diego

Arthur R. Grossman

Arthur R. Grossman

Carnegie Institution for Science

Tero Ahola

Tero Ahola

University of Helsinki

Katrin Meusburger

Katrin Meusburger

Swiss Federal Institute for Forest, Snow and Landscape Research

Folkard Wittrock

Folkard Wittrock

University of Bremen

Christian Cajochen

Christian Cajochen

University of Basel

Dale T. Miller

Dale T. Miller

Stanford University

James R. McKay

James R. McKay

University of Pennsylvania

Something went wrong. Please try again later.